Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 1901-1950 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT07099222
Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks
PHASE1/PHASE2Active, not recruiting
100 participants
Started: Oct 10, 2024 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location
NCT06578949
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
PHASE3Active, not recruiting
18 participants
Started: Oct 10, 2024 · Completed: Jan 14, 2026
2 conditions1 sponsor8 locations
NCT06497270
A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the DISC-OVARY Trial
NAActive, not recruiting
3 participants
Started: Oct 10, 2024 · Completed: Jun 1, 2027
6 conditions1 sponsor1 location
NCT06626711
Effect of Propofol and Sevoflurane Anesthesia on HSP70 Expression in Tumor Cells
EARLY_PHASE1Active, not recruiting
10 participants
Started: Oct 10, 2024 · Completed: Dec 30, 2025
3 conditions3 sponsors1 location
NCT06096792
Muscle Recovery After Total Knee Arthroplasty
N/AActive, not recruiting
20 participants
Started: Oct 10, 2024 · Completed: Sep 11, 2025
1 condition1 sponsor1 location
NCT07216677
A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases
N/AActive, not recruiting
300 participants
Started: Oct 10, 2024 · Completed: Oct 25, 2027
3 conditions1 sponsor1 location
NCT06687902
Value of Digital Breast Tomosynthesis in Breast Lesions
NAActive, not recruiting
50 participants
Started: Oct 9, 2024 · Completed: Dec 6, 2025
1 condition1 sponsor1 location
NCT06680167
Hyperbaric Prilocaine 2% vs Hyperbaric Bupivacaine 0.5% in Caesarean Section
EARLY_PHASE1Active, not recruiting
142 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06644092
Investigation of the Effectiveness of Physiotherapy and Rehabilitation After Osteochondral Allograft Transplantation Operation
NAActive, not recruiting
34 participants
Started: Oct 9, 2024 · Completed: May 9, 2025
4 conditions1 sponsor1 location
NCT06583031
Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years
PHASE1Active, not recruiting
385 participants
Started: Oct 9, 2024 · Completed: Sep 28, 2025
2 conditions1 sponsor6 locations
NCT06630286
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
PHASE3Active, not recruiting
609 participants
Started: Oct 9, 2024 · Completed: Aug 31, 2030
1 condition1 sponsor106 locations
NCT06608212
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
N/AActive, not recruiting
150,000 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06588257
Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study
PHASE4Active, not recruiting
101 participants
Started: Oct 9, 2024 · Completed: Apr 9, 2026
1 condition2 sponsors1 location
NCT06593236
Association of Digital Aid Use With Infant Sleep and Maternal Mental Health
N/AActive, not recruiting
120 participants
Started: Oct 8, 2024 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT06488833
Evaluation of First Year Implementation of Komtü Programme to Improve Emotional Well-being in School.
NAActive, not recruiting
270 participants
Started: Oct 8, 2024 · Completed: May 31, 2025
2 conditions2 sponsors1 location
NCT06599216
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer
PHASE2Active, not recruiting
30 participants
Started: Oct 8, 2024 · Completed: Sep 1, 2027
2 conditions1 sponsor2 locations
NCT06579105
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.
PHASE2Active, not recruiting
406 participants
Started: Oct 8, 2024 · Completed: Dec 19, 2025
1 condition1 sponsor97 locations
NCT07041541
Clinical Evaluation of Gingivalstat Approach Compared to Conventional Esthetic Crown Lengthening on the Stability of The Gingival Margin in Patients With Altered Passive Eruption.
NAActive, not recruiting
22 participants
Started: Oct 8, 2024 · Completed: Jun 1, 2026
3 conditions1 sponsor1 location
NCT06672055
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection
PHASE2Active, not recruiting
10,400 participants
Started: Oct 8, 2024 · Completed: Nov 30, 2026
2 conditions1 sponsor145 locations
NCT06590935
Endocrine and Exocrine Secretory Function Alterations After Moderately Severe and Severe Acute Pancreatitis
N/AActive, not recruiting
120 participants
Started: Oct 8, 2024 · Completed: Sep 30, 2026
2 conditions2 sponsors1 location
NCT05106361
MOSAIC (MOthers' AdvocateS In the Community) for Pregnant Women and Mothers of Children Under 5 With Experience of Intimate Partner Violence
NAActive, not recruiting
40 participants
Started: Oct 8, 2024 · Completed: Jan 20, 2026
3 conditions1 sponsor1 location
NCT06579092
Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity
PHASE2Active, not recruiting
310 participants
Started: Oct 8, 2024 · Completed: Dec 9, 2025
1 condition1 sponsor62 locations
NCT06630299
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
PHASE3Active, not recruiting
600 participants
Started: Oct 8, 2024 · Completed: Aug 31, 2030
1 condition1 sponsor100 locations
NCT06513312
Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)
PHASE2Active, not recruiting
268 participants
Started: Oct 7, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor14 locations
NCT06734468
Personalized Approach to Promote Healthy Aging
NAActive, not recruiting
25 participants
Started: Oct 7, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06533150
Functionalized Bioink Delivering Biomolecules for the Treatment of Craniofacial Diseases
N/AActive, not recruiting
180 participants
Started: Oct 7, 2024 · Completed: Oct 1, 2026
3 conditions1 sponsor1 location
NCT06492174
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort
PHASE3Active, not recruiting
20 participants
Started: Oct 7, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor11 locations
NCT06666296
Sustainable Eating for a Healthy Tomorrow - Effectiveness of Digital Nutrition Workshops to Implement the Planetary Health Diet for Hospital Employees
NAActive, not recruiting
64 participants
Started: Oct 7, 2024 · Completed: Nov 30, 2027
2 conditions2 sponsors1 location
NCT06585891
Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy Adults
PHASE1Active, not recruiting
24 participants
Started: Oct 7, 2024 · Completed: Jun 9, 2027
1 condition1 sponsor1 location
NCT06602479
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
PHASE2Active, not recruiting
12 participants
Started: Oct 7, 2024 · Completed: Sep 15, 2025
1 condition2 sponsors54 locations
NCT05818254
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
NAActive, not recruiting
14 participants
Started: Oct 7, 2024 · Completed: Jul 14, 2026
2 conditions4 sponsors1 location
NCT07155499
A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.
PHASE1/PHASE2Active, not recruiting
150 participants
Started: Oct 7, 2024 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT06200194
Early Intervention for Premyopic Children
PHASE2Active, not recruiting
240 participants
Started: Oct 6, 2024 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT06642506
Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma
N/AActive, not recruiting
20 participants
Started: Oct 6, 2024 · Completed: Sep 30, 2025
8 conditions3 sponsors1 location
NCT06255808
Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor
N/AActive, not recruiting
200 participants
Started: Oct 5, 2024 · Completed: Apr 5, 2025
5 conditions1 sponsor1 location
NCT06602765
Comparative Analysis of Interventions for Prevention of Dental Caries in School Children
NAActive, not recruiting
180 participants
Started: Oct 5, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06644846
Spatially Fractionated Radiation Treatment for Gynaecological Cancers
NAActive, not recruiting
20 participants
Started: Oct 4, 2024 · Completed: Feb 28, 2029
3 conditions1 sponsor1 location
NCT06454916
Functional Lumen Opening With Self-Forming Magnetic Anastomosis
NAActive, not recruiting
70 participants
Started: Oct 4, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor7 locations
NCT06087575
Early Feasibility Study of the Supira System in Patients Undergoing HRPCI
NAActive, not recruiting
20 participants
Started: Oct 4, 2024 · Completed: Jun 30, 2025
3 conditions1 sponsor4 locations
NCT07136233
Impact of Benefit Inserts on Health Plan Selection and Utilization Among Renewing Covered California Members
NAActive, not recruiting
1,600,000 participants
Started: Oct 4, 2024 · Completed: Jul 30, 2026
1 condition1 sponsor1 location
NCT06417814
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE3Active, not recruiting
744 participants
Started: Oct 4, 2024 · Completed: May 29, 2028
1 condition2 sponsors284 locations
NCT06308055
Abiomed Impella RT-DAQ - Observational Study
N/AActive, not recruiting
125 participants
Started: Oct 4, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor5 locations
NCT06648967
Impact of Different Carbohydrate Feedings on a Hydrogen Breath Curve and Self-reported Gastrointestinal Complaints
NAActive, not recruiting
5 participants
Started: Oct 3, 2024 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT06517940
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
N/AActive, not recruiting
12 participants
Started: Oct 3, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06696339
Assessment of Heart Rate Measurement Accuracy for the PreemptiveAI SDK in Adults
N/AActive, not recruiting
100 participants
Started: Oct 3, 2024 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT07134803
ACCURATE ORTHODONTIC BRACKETS POSITIONING WITH OR WITHOUT DENTAL MAGNIFYING LOUPES
NAActive, not recruiting
18 participants
Started: Oct 2, 2024 · Completed: Oct 30, 2025
3 conditions1 sponsor1 location
NCT06531408
Predicting Incidental Gallbladder Cancer
N/AActive, not recruiting
30,000 participants
Started: Oct 2, 2024 · Completed: Sep 30, 2029
1 condition8 sponsors1 location
NCT06748157
Non-Invasive Median Nerve Stimulation to Attenuate Atrial Tachyarrhythmias After Catheter Ablation for Atrial Fibrillation
NAActive, not recruiting
34 participants
Started: Oct 2, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06587568
Mobile Chat Messaging for Alcohol Reduction in Patients With Chronic Liver Diseases
NAActive, not recruiting
106 participants
Started: Oct 2, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06270875
Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)
NAActive, not recruiting
10 participants
Started: Oct 2, 2024 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location